The Effect of Polycystic Ovary Syndrome Treatment on Metabolomics
Status:
Recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to determine the effect of the treatment of polycystic ovary
syndrome with two different oral contraceptives that contain cyproterone acetate and
drospirenone
Phase:
N/A
Details
Lead Sponsor:
Inonu University
Treatments:
Cyproterone acetate, ethinyl estradiol drug combination